skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation

Review

(1611) Views  (608) Full article downloads

Authors: Gaurav Gupta, Karl L Womer

Published Date December 2010 Volume 2010:4 Pages 375 - 382
DOI: http://dx.doi.org/10.2147/DDDT.S10432

Gaurav Gupta, Karl L Womer
Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Abstract: The last several decades have witnessed a substantial decrease in the incidence of acute allograft rejection following kidney transplantation, although commensurate improvements in long-term graft function have not been realized. As a result, the primary focus of new immunosuppressive drug development has expanded to include ease of use and improved side effect profile, including reduced nephrotoxicity, in addition to the more traditional goal of improved short-term outcomes. A number of novel drugs are currently under investigation in Phase I, II, or III clinical trials, primarily to replace the nephrotoxic but highly effective calcineurin inhibitors. Belatacept is a humanized antibody that inhibits T cell costimulation and has shown encouraging results in multiple Phase II and III trials. This article reviews the mechanism of action of belatacept, as well as published and preliminary results of the Phase I–III clinical trials involving this novel immunosuppressive agent.

Keywords: kidney transplantation, T cell costimulation, immunosuppression, graft rejection, post-transplant lymphoproliferative disease






Readers of this article also read:

Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Axial eye length measurements pre- and post- laser-assisted in situ keratomileusis using the IOL Master: a pilot study
Trinidadian women’s knowledge, perceptions, and preferences regarding cesarean section: How do they make choices?
Erratum - Intracellular heavy metal nanoparticle storage
Erratum
Critical appraisal of belatacept for prophylaxis of rejection in kidney transplant patients
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Primary care for diabetes mellitus: perspective from older patients
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University